Global Large Volume Parenterals (LVP) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Large Volume Parenterals (LVP) market report explains the definition, types, applications, major countries, and major players of the Large Volume Parenterals (LVP) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Beximco Pharma (Bangladesh)

    • BAG Healthcare (Germany)

    • Baxter Healthcare Corporation (US)

    • Kelun Pharma (China)

    • Patheon Inc (Netherlands)

    • Ostuka Pharmaceutical (Japan)

    • Cook Pharmica LLC (Catalent) (US)

    • Teva Pharmaceutical Industries Limited (Israel)

    • Southwest Pharmaceutical Co Ltd (China)

    By Type:

    • Fluid Balance Injections

    • Therapeutic Injections

    • Nutritious Injections

    By End-User:

    • Intravenous

    • Intramuscular

    • Subcutaneous

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Large Volume Parenterals (LVP) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Large Volume Parenterals (LVP) Outlook to 2028- Original Forecasts

    • 2.2 Large Volume Parenterals (LVP) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Large Volume Parenterals (LVP) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Large Volume Parenterals (LVP) Market- Recent Developments

    • 6.1 Large Volume Parenterals (LVP) Market News and Developments

    • 6.2 Large Volume Parenterals (LVP) Market Deals Landscape

    7 Large Volume Parenterals (LVP) Raw Materials and Cost Structure Analysis

    • 7.1 Large Volume Parenterals (LVP) Key Raw Materials

    • 7.2 Large Volume Parenterals (LVP) Price Trend of Key Raw Materials

    • 7.3 Large Volume Parenterals (LVP) Key Suppliers of Raw Materials

    • 7.4 Large Volume Parenterals (LVP) Market Concentration Rate of Raw Materials

    • 7.5 Large Volume Parenterals (LVP) Cost Structure Analysis

      • 7.5.1 Large Volume Parenterals (LVP) Raw Materials Analysis

      • 7.5.2 Large Volume Parenterals (LVP) Labor Cost Analysis

      • 7.5.3 Large Volume Parenterals (LVP) Manufacturing Expenses Analysis

    8 Global Large Volume Parenterals (LVP) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Large Volume Parenterals (LVP) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Large Volume Parenterals (LVP) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Large Volume Parenterals (LVP) Market Outlook by Types and Applications to 2022

    • 9.1 Global Large Volume Parenterals (LVP) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Fluid Balance Injections Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Therapeutic Injections Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Nutritious Injections Consumption and Growth Rate (2017-2022)

    • 9.2 Global Large Volume Parenterals (LVP) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Intravenous Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Intramuscular Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Subcutaneous Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Large Volume Parenterals (LVP) Market Analysis and Outlook till 2022

    • 10.1 Global Large Volume Parenterals (LVP) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.2.2 Canada Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.2.3 Mexico Large Volume Parenterals (LVP) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.3.2 UK Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.3.3 Spain Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.3.4 Belgium Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.3.5 France Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.3.6 Italy Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.3.7 Denmark Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.3.8 Finland Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.3.9 Norway Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.3.10 Sweden Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.3.11 Poland Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.3.12 Russia Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.3.13 Turkey Large Volume Parenterals (LVP) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.4.2 Japan Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.4.3 India Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.4.4 South Korea Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.4.5 Pakistan Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.4.6 Bangladesh Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.4.7 Indonesia Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.4.8 Thailand Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.4.9 Singapore Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.4.10 Malaysia Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.4.11 Philippines Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.4.12 Vietnam Large Volume Parenterals (LVP) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.5.2 Colombia Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.5.3 Chile Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.5.4 Argentina Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.5.5 Venezuela Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.5.6 Peru Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.5.8 Ecuador Large Volume Parenterals (LVP) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.6.2 Kuwait Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.6.3 Oman Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.6.4 Qatar Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Large Volume Parenterals (LVP) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.7.2 South Africa Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.7.3 Egypt Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.7.4 Algeria Large Volume Parenterals (LVP) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Large Volume Parenterals (LVP) Consumption (2017-2022)

      • 10.8.2 New Zealand Large Volume Parenterals (LVP) Consumption (2017-2022)

    11 Global Large Volume Parenterals (LVP) Competitive Analysis

    • 11.1 Beximco Pharma (Bangladesh)

      • 11.1.1 Beximco Pharma (Bangladesh) Company Details

      • 11.1.2 Beximco Pharma (Bangladesh) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Beximco Pharma (Bangladesh) Large Volume Parenterals (LVP) Main Business and Markets Served

      • 11.1.4 Beximco Pharma (Bangladesh) Large Volume Parenterals (LVP) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 BAG Healthcare (Germany)

      • 11.2.1 BAG Healthcare (Germany) Company Details

      • 11.2.2 BAG Healthcare (Germany) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 BAG Healthcare (Germany) Large Volume Parenterals (LVP) Main Business and Markets Served

      • 11.2.4 BAG Healthcare (Germany) Large Volume Parenterals (LVP) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Baxter Healthcare Corporation (US)

      • 11.3.1 Baxter Healthcare Corporation (US) Company Details

      • 11.3.2 Baxter Healthcare Corporation (US) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Baxter Healthcare Corporation (US) Large Volume Parenterals (LVP) Main Business and Markets Served

      • 11.3.4 Baxter Healthcare Corporation (US) Large Volume Parenterals (LVP) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Kelun Pharma (China)

      • 11.4.1 Kelun Pharma (China) Company Details

      • 11.4.2 Kelun Pharma (China) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Kelun Pharma (China) Large Volume Parenterals (LVP) Main Business and Markets Served

      • 11.4.4 Kelun Pharma (China) Large Volume Parenterals (LVP) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Patheon Inc (Netherlands)

      • 11.5.1 Patheon Inc (Netherlands) Company Details

      • 11.5.2 Patheon Inc (Netherlands) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Patheon Inc (Netherlands) Large Volume Parenterals (LVP) Main Business and Markets Served

      • 11.5.4 Patheon Inc (Netherlands) Large Volume Parenterals (LVP) Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Ostuka Pharmaceutical (Japan)

      • 11.6.1 Ostuka Pharmaceutical (Japan) Company Details

      • 11.6.2 Ostuka Pharmaceutical (Japan) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Ostuka Pharmaceutical (Japan) Large Volume Parenterals (LVP) Main Business and Markets Served

      • 11.6.4 Ostuka Pharmaceutical (Japan) Large Volume Parenterals (LVP) Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Cook Pharmica LLC (Catalent) (US)

      • 11.7.1 Cook Pharmica LLC (Catalent) (US) Company Details

      • 11.7.2 Cook Pharmica LLC (Catalent) (US) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Cook Pharmica LLC (Catalent) (US) Large Volume Parenterals (LVP) Main Business and Markets Served

      • 11.7.4 Cook Pharmica LLC (Catalent) (US) Large Volume Parenterals (LVP) Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Teva Pharmaceutical Industries Limited (Israel)

      • 11.8.1 Teva Pharmaceutical Industries Limited (Israel) Company Details

      • 11.8.2 Teva Pharmaceutical Industries Limited (Israel) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Teva Pharmaceutical Industries Limited (Israel) Large Volume Parenterals (LVP) Main Business and Markets Served

      • 11.8.4 Teva Pharmaceutical Industries Limited (Israel) Large Volume Parenterals (LVP) Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Southwest Pharmaceutical Co Ltd (China)

      • 11.9.1 Southwest Pharmaceutical Co Ltd (China) Company Details

      • 11.9.2 Southwest Pharmaceutical Co Ltd (China) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Southwest Pharmaceutical Co Ltd (China) Large Volume Parenterals (LVP) Main Business and Markets Served

      • 11.9.4 Southwest Pharmaceutical Co Ltd (China) Large Volume Parenterals (LVP) Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Large Volume Parenterals (LVP) Market Outlook by Types and Applications to 2028

    • 12.1 Global Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Fluid Balance Injections Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Therapeutic Injections Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Nutritious Injections Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Intravenous Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Intramuscular Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Large Volume Parenterals (LVP) Market Analysis and Outlook to 2028

    • 13.1 Global Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.3.2 UK Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.3.5 France Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.4.3 India Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Large Volume Parenterals (LVP) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Large Volume Parenterals (LVP)

    • Figure of Large Volume Parenterals (LVP) Picture

    • Table Global Large Volume Parenterals (LVP) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Large Volume Parenterals (LVP) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Fluid Balance Injections Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutic Injections Consumption and Growth Rate (2017-2022)

    • Figure Global Nutritious Injections Consumption and Growth Rate (2017-2022)

    • Figure Global Intravenous Consumption and Growth Rate (2017-2022)

    • Figure Global Intramuscular Consumption and Growth Rate (2017-2022)

    • Figure Global Subcutaneous Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Large Volume Parenterals (LVP) Consumption by Country (2017-2022)

    • Table North America Large Volume Parenterals (LVP) Consumption by Country (2017-2022)

    • Figure United States Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Canada Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Table Europe Large Volume Parenterals (LVP) Consumption by Country (2017-2022)

    • Figure Germany Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure UK Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Spain Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure France Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Italy Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Finland Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Norway Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Poland Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Russia Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Table APAC Large Volume Parenterals (LVP) Consumption by Country (2017-2022)

    • Figure China Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Japan Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure India Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Table South America Large Volume Parenterals (LVP) Consumption by Country (2017-2022)

    • Figure Brazil Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Chile Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Peru Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Table GCC Large Volume Parenterals (LVP) Consumption by Country (2017-2022)

    • Figure Bahrain Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Oman Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Table Africa Large Volume Parenterals (LVP) Consumption by Country (2017-2022)

    • Figure Nigeria Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Table Oceania Large Volume Parenterals (LVP) Consumption by Country (2017-2022)

    • Figure Australia Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Large Volume Parenterals (LVP) Consumption and Growth Rate (2017-2022)

    • Table Beximco Pharma (Bangladesh) Company Details

    • Table Beximco Pharma (Bangladesh) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beximco Pharma (Bangladesh) Large Volume Parenterals (LVP) Main Business and Markets Served

    • Table Beximco Pharma (Bangladesh) Large Volume Parenterals (LVP) Product Portfolio

    • Table BAG Healthcare (Germany) Company Details

    • Table BAG Healthcare (Germany) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table BAG Healthcare (Germany) Large Volume Parenterals (LVP) Main Business and Markets Served

    • Table BAG Healthcare (Germany) Large Volume Parenterals (LVP) Product Portfolio

    • Table Baxter Healthcare Corporation (US) Company Details

    • Table Baxter Healthcare Corporation (US) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Healthcare Corporation (US) Large Volume Parenterals (LVP) Main Business and Markets Served

    • Table Baxter Healthcare Corporation (US) Large Volume Parenterals (LVP) Product Portfolio

    • Table Kelun Pharma (China) Company Details

    • Table Kelun Pharma (China) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kelun Pharma (China) Large Volume Parenterals (LVP) Main Business and Markets Served

    • Table Kelun Pharma (China) Large Volume Parenterals (LVP) Product Portfolio

    • Table Patheon Inc (Netherlands) Company Details

    • Table Patheon Inc (Netherlands) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Patheon Inc (Netherlands) Large Volume Parenterals (LVP) Main Business and Markets Served

    • Table Patheon Inc (Netherlands) Large Volume Parenterals (LVP) Product Portfolio

    • Table Ostuka Pharmaceutical (Japan) Company Details

    • Table Ostuka Pharmaceutical (Japan) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ostuka Pharmaceutical (Japan) Large Volume Parenterals (LVP) Main Business and Markets Served

    • Table Ostuka Pharmaceutical (Japan) Large Volume Parenterals (LVP) Product Portfolio

    • Table Cook Pharmica LLC (Catalent) (US) Company Details

    • Table Cook Pharmica LLC (Catalent) (US) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cook Pharmica LLC (Catalent) (US) Large Volume Parenterals (LVP) Main Business and Markets Served

    • Table Cook Pharmica LLC (Catalent) (US) Large Volume Parenterals (LVP) Product Portfolio

    • Table Teva Pharmaceutical Industries Limited (Israel) Company Details

    • Table Teva Pharmaceutical Industries Limited (Israel) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Limited (Israel) Large Volume Parenterals (LVP) Main Business and Markets Served

    • Table Teva Pharmaceutical Industries Limited (Israel) Large Volume Parenterals (LVP) Product Portfolio

    • Table Southwest Pharmaceutical Co Ltd (China) Company Details

    • Table Southwest Pharmaceutical Co Ltd (China) Large Volume Parenterals (LVP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Southwest Pharmaceutical Co Ltd (China) Large Volume Parenterals (LVP) Main Business and Markets Served

    • Table Southwest Pharmaceutical Co Ltd (China) Large Volume Parenterals (LVP) Product Portfolio

    • Figure Global Fluid Balance Injections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutic Injections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nutritious Injections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intravenous Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intramuscular Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Large Volume Parenterals (LVP) Consumption Forecast by Country (2022-2028)

    • Table North America Large Volume Parenterals (LVP) Consumption Forecast by Country (2022-2028)

    • Figure United States Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Large Volume Parenterals (LVP) Consumption Forecast by Country (2022-2028)

    • Figure Germany Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Large Volume Parenterals (LVP) Consumption Forecast by Country (2022-2028)

    • Figure China Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Large Volume Parenterals (LVP) Consumption Forecast by Country (2022-2028)

    • Figure Brazil Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Large Volume Parenterals (LVP) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Large Volume Parenterals (LVP) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Large Volume Parenterals (LVP) Consumption Forecast by Country (2022-2028)

    • Figure Australia Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Large Volume Parenterals (LVP) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.